Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Geisbert

Showing results (191-200 of 279) with videos related to

Pageof 28
Sort By:
Journal of Virology|December 18, 2015
Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR PathwaySowmya Pattabhi, Courtney R Wilkins, Ran Dong, et al.
The Journal of Infectious Diseases|May 5, 2023
Pathogenesis of Aerosolized Ebola Virus Variant Makona in Nonhuman PrimatesAbhishek N Prasad, Karla A Fenton, Krystle N Agans, et al.
Scientific Reports|March 14, 2023
Natural history of nonhuman primates after conjunctival exposure to Ebola virusRobert W Cross, Abhishek N Prasad, Courtney B Woolsey, et al.
Cell Reports|September 19, 2019
A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus ChallengeCourtney Woolsey, Andrea R Menicucci, Robert W Cross, et al.
Nature Medicine|June 7, 2005
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg virusesSteven M Jones, Heinz Feldmann, Ute Ströher, et al.
Emerging Infectious Diseases|November 4, 2008
Framework for leadership and training of Biosafety Level 4 laboratory workersJames W Le Duc, Kevin Anderson, Marshall E Bloom, et al.
Frontiers in Immunology|September 6, 2021
Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg VirusesAxel T Lehrer, Eleanore Chuang, Madhuri Namekar, et al.
Journal of Virology|February 18, 2011
Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challengeThomas W Geisbert, Michael Bailey, Lisa Hensley, et al.
Antiviral Research|August 18, 2016
Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodiesRobert W Cross, Chad E Mire, Luis M Branco, et al.
The Journal of Infectious Diseases|May 17, 2006
Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interferenceThomas W Geisbert, Lisa E Hensley, Elliott Kagan, et al.
Pageof 28

Showing results (191-200 of 279) with videos related to

Sort By:
Pageof 28
Journal of Virology|December 18, 2015
Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR PathwaySowmya Pattabhi, Courtney R Wilkins, Ran Dong, et al.
The Journal of Infectious Diseases|May 5, 2023
Pathogenesis of Aerosolized Ebola Virus Variant Makona in Nonhuman PrimatesAbhishek N Prasad, Karla A Fenton, Krystle N Agans, et al.
Scientific Reports|March 14, 2023
Natural history of nonhuman primates after conjunctival exposure to Ebola virusRobert W Cross, Abhishek N Prasad, Courtney B Woolsey, et al.
Cell Reports|September 19, 2019
A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus ChallengeCourtney Woolsey, Andrea R Menicucci, Robert W Cross, et al.
Nature Medicine|June 7, 2005
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg virusesSteven M Jones, Heinz Feldmann, Ute Ströher, et al.
Emerging Infectious Diseases|November 4, 2008
Framework for leadership and training of Biosafety Level 4 laboratory workersJames W Le Duc, Kevin Anderson, Marshall E Bloom, et al.
Frontiers in Immunology|September 6, 2021
Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg VirusesAxel T Lehrer, Eleanore Chuang, Madhuri Namekar, et al.
Journal of Virology|February 18, 2011
Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challengeThomas W Geisbert, Michael Bailey, Lisa Hensley, et al.
Antiviral Research|August 18, 2016
Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodiesRobert W Cross, Chad E Mire, Luis M Branco, et al.
The Journal of Infectious Diseases|May 17, 2006
Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interferenceThomas W Geisbert, Lisa E Hensley, Elliott Kagan, et al.
Pageof 28